Results 11 to 20 of about 128,340 (326)
Viral Hepatitis and Rapid Diagnostic Test Based Screening for HBsAg in HIV-infected Patients in Rural Tanzania [PDF]
PLoS ONE, 2013 Background Co-infection with hepatitis B virus (HBV) is highly prevalent in people living with HIV in Sub-Saharan Africa. Screening for HBV surface antigen (HBsAg) before initiation of combination antiretroviral therapy (cART) is recommended. However, it
F. Franzeck +10 more
semanticscholar +23 more sources
IL-10 Promoter Polymorphism Distribution among HBsAg-Reactive and HBsAg-Nonreactive Blood Donors
Majalah Kedokteran Bandung, 2020 Hepatitis B surface antigen (HBsAg) serves as a serological marker for Hepatitis B virus (HBV) infection. People with HBV asymptomatic infection might readily donate blood due to the lack of clinical manifestations.
Rahmat Azhari Kemal +5 more
doaj +1 more source
The role of Recombinant interleukin-2 in the treatment of patients with chronic hepatitis B.
Инфекция и иммунитет, 2023 Dysregulated immune response occurring in chronic hepatitis B prevents the virus elimination and contributes to progression of the infectious process.
Anastasiya F. Novikova +2 more
doaj +1 more source
Hepatology, EarlyView., 2022 Adaptive mitochondrial mechanisms allow mitochondrial resilience and prevent the worsening of fibrosis, while deregulation of these mechanisms promotes the progression from no/minimal‐mild (F0‐F2) fibrosis to advanced fibrosis and cirrhosis (F3‐F4). Abstract Background and Aims Hepatitis B virus (HBV) infection causes oxidative stress (OS) and alters ...
Dimitri Loureiro +17 more
wiley +1 more source
PreHevbrio: the first approved 3-antigen hepatitis B vaccine
Expert Review of Vaccines, 2023 Introduction Hepatitis B remains a major cause of death and morbidity worldwide. Universal childhood immunization programs have been very successful, but many adults remain unprotected or are not optimally protected.
Timo Vesikari +3 more
doaj +1 more source
Human Vaccines & Immunotherapeutics, 2021 Recommendations promoted worldwide have suggested a period of protection lasting more than 20 years against hepatitis B (HB) following primary immunization. Starting in 1987, universal HB vaccinations were carried out in Long An County, Guangxi Province,
Zhigang Zheng +8 more
doaj +1 more source
Hepatitis B infection among hemodialysis patients in Al-Jazirah State: a seroepidemiological survey
Current Issues in Pharmacy and Medical Sciences, 2023 Hemodialysis patients are more susceptible to HBV infection because they have low immunity and can be inflicted through an improperly sterilized machine or through a tainted blood transfusion.
Moglad Ehssan H. O. +2 more
doaj +1 more source
JGH Open, Volume 6, Issue 12, Page 894-903, December 2022., 2022 We assessed treatment and cost outcomes for integrated HIV and viral hepatitis testing with ledipasvir/sofosbuvir ± weight‐based ribavirin for 12 weeks in Kyiv, Ukraine. Overall, a sustained virological response (SVR) was achieved in 831 of 868 patients (95.7%).
Sergie Antoniak +24 more
wiley +1 more source
How does the immunogenicity of hepatitis B vaccine change over the years in childhood?
Human Vaccines & Immunotherapeutics, 2021 Hepatitis B is the leading cause of chronic hepatitis, cirrhosis, and hepatocellular carcinoma worldwide. The incidence of HBV infection has significantly decreased with hepatitis B vaccination. Hepatitis B vaccine is administered to children at 0, 1 and
Gulsum Iclal Bayhan +3 more
doaj +1 more source
Scientific Reports, 2020 Chronic hepatitis B (CHB) infection functional cure is defined as sustained loss of HBsAg and several therapeutic strategies are in clinical development designed to pharmacologically reduce serum HBsAg, break immune tolerance, and increase functional ...
Jin Hyang Kim +11 more
semanticscholar +1 more source